Regulus Therapeutics Inc. (RGLS) Social Stream



Regulus Therapeutics Inc. (RGLS): $0.19

-0.03 (-12.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RGLS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 491

in industry

Regulus Therapeutics Inc (RGLS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Regulus Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-10 3 $2 $1 $1.666 $0.325 412.62%
2022-03-14 2 $2 $2 $2 $0.325 515.38%

The Trend in the Analyst Price Target


RGLS's average price target has moved up $1 over the prior 22 months.

RGLS reports an average of 141.08% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 2 2 0.5 1.250 0.915 36.61%
2021-08-14 2 2 0.5 1.170 0.671 74.37%
2021-09-20 3 2 0.5 1.380 0.715 93.01%
2021-12-10 3 2 1.0 1.666 0.369 351.49%
2022-03-11 2 2 2.0 2.000 0.285 601.75%

RGLS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 23 months, RGLS's average broker recommendation rating improved by 2.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Regulus Therapeutics Inc's average analyst price target is greater than 0.67% of all US stocks.
  • Regulus Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 191.56% of all US stocks.
  • RGLS has a higher number of analysts covering the stock than 17.24% of Healthcare stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Regulus Therapeutics Inc's variance in analysts' estimates is lower than 26.36% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Regulus Therapeutics Inc are RDHL, RAPT, and RANI.

Is RGLS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.0389 seconds.